Is KOPN a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Kopin Corporation (KOPN) rests on Color MicroLED for the U.S. Army: Kopin's IBAS funded program cleared several thresholds in mid 2026, including single panel full color brightness above 150,000 nits and the installation of U.S. The bear case rests on valuation is the first order risk: about 23 times trailing sales is a demanding multiple for a company whose product revenue grew 2% year over year last quarter and whose cost of product revenue consumed 93% of product sales across the first half of 2026. Analysts covering it publish targets from $6.50 to $12.00 against a $5.50 price, so even the professionals disagree by 63% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Kopin Corporation has been building miniature displays since 1984, and the core business is unglamorous: liquid crystal and OLED microdisplays, plus the optical lenses and modules built around them, sold into thermal weapon sights, training and simulation rigs, 3D metrology machines and medical headsets. Defense is where the money actually comes from, contributing about $7.3 million of the $7.6 million in product revenue booked in the second quarter of 2026. Three newer lines sit on top of that base. The company is developing full color MicroLED under a U.S. Government Industrial Base Analysis and Sustainment award, aimed at ground soldier vision systems; it has launched Sentinel FPV, a first person view drone product pitched at the U.S. Government's one way attack drone initiative; and through a joint development agreement with Fabric.AI it is working on Neural I/o, a GPU to GPU optical interconnect for AI infrastructure. Kopin also owns a 19.99% stake in Fabric.AI and, since October 2025, has a European defense partner in Theon, which took 49% of subsidiary Kopin Europe for $8.0 million. The investment picture turns on a gap between the two halves of the revenue line. Total second quarter revenue rose 51% year over year to about $12.7 million, which reads impressively until you separate it: product revenue was roughly $7.6 million, up about 2%, while non product revenue (government grants, funded R&D and collaboration income) went from about $1.0 million to about $5.1 million. Grant and development money is real cash and it validates the technology, but it is program dependent and it does not compound the way product shipments do. Meanwhile the cost of product revenue ran at 86% of product revenue in the quarter and 93% across the first half, so the shipping business is close to breakeven at the gross line. The balance sheet is unlevered, with about $50.3 million of cash, restricted cash and securities against no borrowings, though $25.4 million of that is locked in a supersedeas bond backing a $19.7 million trade secrets judgment now on appeal. At roughly 23 times trailing sales for a company with a $10 million trailing operating loss, the multiple already assumes the MicroLED, drone and interconnect programs convert.
The bull case: what would have to be true for $12.00
The most optimistic published target on KOPN is $12.00, +118.2% from the $5.50 price as of August 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Color MicroLED for the U.S. Army
Kopin's IBAS funded program cleared several thresholds in mid 2026, including single panel full color brightness above 150,000 nits and the installation of U.S. based MicroLED bonding equipment at Westborough. Management is targeting a transition to domestic MicroLED production in mid 2027, with the Soldier Borne Mission Command program named as the kind of long lived contract this capability is meant to serve. Displacing incumbent night vision and weapon sight optics is a slow, qualification heavy process, so the revenue attached to this work is a 2027 and beyond proposition rather than a 2026 one.
2. Sentinel FPV and the Drone Dominance Program
The company reported multiple prototype orders for its Sentinel FPV system from customers competing in the U.S. Government's Drone Dominance Program, with volume orders expected to begin following Phase 2 evaluations and awards in late August 2026. Kopin points to its dual situational awareness design and to domestic manufacturing as the differentiators in a category where supply chain provenance is itself a selection criterion. Prototype orders are cheap and production awards are not, so the size and timing of any Phase 2 conversion is the specific thing to watch.
3. Neural I/o and AI interconnect
Under an April 2026 joint development agreement with Fabric.AI, Kopin is building toward a 1.6 terabit per second optical transceiver aimed at GPU to GPU connectivity, with a demonstration planned for CES in January 2027. The company has signed non disclosure agreements with several current NVIDIA NVLink partners and opened an optics and photonics design center in Dallas to support the work. This is the newest and least proven of the three programs, and it puts a display company into a market contested by Broadcom, Marvell and the optical module incumbents.
4. The Theon relationship and European defense demand
Theon paid $8.0 million for 49% of Kopin Europe in October 2025 and separately bought $7.0 million of convertible preferred, which it converted at $3.00 per share in May 2026. The agreement pairs Kopin's display technology with a partner already selling night vision systems into European militaries, and it produced the collaboration revenue that shows up in the 2026 numbers. Rising European defense budgets are the tailwind here, though the arrangement also means Kopin now books its European display business through an equity method stake rather than consolidating it.
The bear case: what would have to be true for $6.50
The most pessimistic published target is $6.50, +18.2% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Kopin Corporation is worth if the risks below bite instead of the drivers above.
Valuation is the first order risk: about 23 times trailing sales is a demanding multiple for a company whose product revenue grew 2% year over year last quarter and whose cost of product revenue consumed 93% of product sales across the first half of 2026. The growth in the headline revenue line came from grants, funded R&D and collaboration income, which are contract specific and can end when a program phase ends. Litigation remains unresolved: a Colorado jury found for BlueRadios in the trade secrets case and a September 2025 post trial order awarded roughly $19.7 million, which Kopin has accrued, bonded with $23.0 million of restricted cash and appealed to the Federal Circuit, where BlueRadios is cross appealing for additional damages and an injunction that could restrict products incorporating the disputed technology. Separately, Kopin filed a Form NT 10-K on March 27, 2026 citing complex technical accounting considerations before filing its annual report on April 13, and plaintiff firm Johnson Fistel announced an investigation of potential claims on March 31; as of the 10-Q filed August 11, 2026, no securities class action has been filed against the company and its Legal Proceedings note discloses only the BlueRadios matter. Dilution is a standing feature rather than an event, with a 19.5 million share PIPE in September 2025 raising about $38.1 million net and share count now near 179.5 million, and management states liquidity into the fourth quarter of 2027 while continuing to burn cash from operations.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding KOPN already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on KOPN
6 analysts cover KOPN, with an average target of $8.67 (+57.6% against $5.50) and a split of 6 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the KOPN forecast and price target page.
How is KOPN valued? (as of August 2026)
Snapshot for KOPN as of August 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$43.6M
- Q2 2026 total revenue: ~$12.7M, up ~51% year over year
- Q2 2026 product revenue: ~$7.6M, up ~2% year over year
- Operating loss (TTM): ~$10M
- Cash, restricted cash and securities: ~$50.3M, of which ~$25.4M is restricted
- Price to sales (TTM): ~23x
The trailing net income figure of roughly $8.0 million is misleading on its own, because it comes from investment gains, a $2.1 million tax benefit tied to an expiring statute of limitations, and a reduction in the BlueRadios litigation accrual rather than from operations. Strip those out and the business ran an operating loss of about $10 million over the last twelve months on roughly $43.6 million of revenue. Management has guided to a second half exceeding its prior expectations and says it expects meaningful progress toward sustainable GAAP profitability in the fourth quarter of 2026.
How do you decide if KOPN is a buy?
Rather than asking whether KOPN is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold KOPN indirectly through an index or sector ETF before adding more.
What would change your mind on KOPN
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Color MicroLED for the U.S. Army stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: valuation is the first order risk: about 23 times trailing sales is a demanding multiple for a company whose product revenue grew 2% year over year last quarter and whose cost of product revenue consumed 93% of product sales across the first half of 2026 fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the KOPN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about KOPN against your real portfolio and see your actual exposure before deciding.
Investing in Kopin Corporation with AI
Connect the broker you already use and ask Walnut's AI how KOPN fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is KOPN a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Color MicroLED for the U.S. Army, with revenue (ttm) at ~$43.6M. The bear case rests on valuation is the first order risk: about 23 times trailing sales is a demanding multiple for a company whose product revenue grew 2% year over year last quarter and whose cost of product revenue consumed 93% of product sales across the first half of 2026. Analysts covering it are spread from $6.50 to $12.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell KOPN?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Valuation is the first order risk: about 23 times trailing sales is a demanding multiple for a company whose product revenue grew 2% year over year last quarter and whose cost of product revenue consumed 93% of product sales across the first half of 2026. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $6.50, +18.2% from the $5.50 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for KOPN?
+
Color MicroLED for the U.S. Army. Kopin's IBAS funded program cleared several thresholds in mid 2026, including single panel full color brightness above 150,000 nits and the installation of U.S. The most optimistic analyst target on KOPN is $12.00, +118.2% from the $5.50 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for KOPN?
+
Valuation is the first order risk: about 23 times trailing sales is a demanding multiple for a company whose product revenue grew 2% year over year last quarter and whose cost of product revenue consumed 93% of product sales across the first half of 2026. The growth in the headline revenue line came from grants, funded R&D and collaboration income, which are contract specific and can end when a program phase ends. Litigation remains unresolved: a Colorado jury found for BlueRadios in the trade secrets case and a September 2025 post trial order awarded roughly $19.7 million, which Kopin has accrued, bonded with $23.0 million of restricted cash and appealed to the Federal Circuit, where BlueRadios is cross appealing for additional damages and an injunction that could restrict products incorporating the disputed technology. Separately, Kopin filed a Form NT 10-K on March 27, 2026 citing complex technical accounting considerations before filing its annual report on April 13, and plaintiff firm Johnson Fistel announced an investigation of potential claims on March 31; as of the 10-Q filed August 11, 2026, no securities class action has been filed against the company and its Legal Proceedings note discloses only the BlueRadios matter. Dilution is a standing feature rather than an event, with a 19.5 million share PIPE in September 2025 raising about $38.1 million net and share count now near 179.5 million, and management states liquidity into the fourth quarter of 2027 while continuing to burn cash from operations. The most pessimistic published target is $6.50, +18.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Kopin Corporation do?
+
Kopin makes miniature displays and optical systems for military thermal weapon sights, training simulators, FPV drones and AI data center interconnect.
What would have to change for KOPN to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Color MicroLED for the U.S. Army) stalling in the reported numbers rather than in the narrative, the risk above (valuation is the first order risk: about 23 times trailing sales is a demanding multiple for a company whose product revenue grew 2% year over year last quarter and whose cost of product revenue consumed 93% of product sales across the first half of 2026) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Kopin actually sell today?
+
Miniature displays and the optics built around them. Liquid crystal and OLED microdisplays go into thermal weapon sights, training and simulation systems, 3D metrology machines and medical headsets, and defense accounted for about $7.3 million of the $7.6 million of product revenue in the second quarter of 2026. The MicroLED, drone and interconnect programs are development stage on top of that base.
Why did revenue jump 51% if product sales barely moved?
+
The increase came from non product revenue, which went from about $1.0 million to about $5.1 million year over year in the second quarter. That figure is government grant income from the MicroLED award, funded R&D on the U.S. Army heads up display program, and collaboration revenue from Fabric.AI and the AR thermal clip on partnership. Product revenue itself rose about 2%, to roughly $7.6 million.
Is Kopin profitable?
+
Not from operations. The trailing twelve month operating loss is about $10 million, and the positive trailing net income of roughly $8.0 million comes from investment gains, a $2.1 million tax benefit and a reduction in the litigation accrual. The company reported net income of $0.9 million in the second quarter of 2026, again with investment gains and the tax benefit doing most of the work.
Walnut is informational, not investment advice, and gives no verdict on KOPN. Analyst targets referenced here come from a August 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.